-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TAS-1553
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TAS-1553 Drug Details TAS-1553 is under development for the treatment of acute myeloid leukemia,...
-
Product Insights
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Small cell lung cancer (SCLC) is the most aggressive form of lung cancer. These tumors often spread rapidly (metastasize) to other parts of the body, including the brain, liver, and bone. The Small-Cell Lung Cancer market research report provides comprehensive information on the therapeutics under development for SCLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...
-
Product Insights
Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Esophageal cancer symptoms include cough, difficulty swallowing, chest pain, pressure or burning, and weight loss. Predisposing factors include age, smoking, obesity, and bile reflux. Treatment includes chemotherapy, radiation therapy, and surgery. The Esophageal Cancer pipeline drugs market research report provides an overview of the Esophageal Cancer (Oncology) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Esophageal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA),...